Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression

No abstract is available for this paper.

• Publication year

  1992

• Venue

  European Journal of Immunology

• Publication date

  1992-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.1830221111PMID 1425910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Murine H-2Dd-reactive monoclonal antibodies recognize shared antigenic determinant(s) on human HLA-B7 or HLA-B27 molecules or both

  2004cited by this paper
• Induction of tolerance in peripheral T cells with monoclonal antibodies

  1990cited by this paper
• Comparative analysis of in vivo T cell depletion with radiotherapy, combination chemotherapy, and the monoclonal antibody Campath-1G, using limiting dilution methodology.

  1990cited by this paper
• Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?

  1990cited by this paper
• Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

  1989cited by this paper
• Induction of classical transplantation tolerance in the adult

  1989cited by this paper
• Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide

  1989cited by this paper
• Peripheral lymph node helper T-cell recovery after syngeneic bone marrow transplantation in mice prepared with either gamma-irradiation or busulfan.

  1989cited by this paper
• Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts.

  1989cited by this paper
• Mixed allogeneic chimerism as an approach to transplantation tolerance.

  1988cited by this paper
• Failure to induce chimerism or tolerance in mice with monoclonal anti-T cell antibodies plus allogeneic bone marrow infusion.

  1988cited by this paper
• CD4 monoclonal antibody pairs for immunosuppression and tolerance induction

  1987cited by this paper
• Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance

  1986cited by this paper
• Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

  1984cited by this paper
• The early complications of bone marrow transplantation.

  1984cited by this paper
• COMPARISON OF ALLOGENEIC AND XENOGENEIC DETERMINANTS ON THE H‐2Kk MOLECULE

  1983cited by this paper
• Fractionated Total Lymphoid Irradiation as Preparative Immunosuppression in High Risk Renal Transplantation: Clinical and Immunological Studies

  1982cited by this paper
• Monoclonal Antibodies Against Rat Immunoglobulin Kappa Chains

  1982cited by this paper
• Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

  1981cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

  1977cited by this paper
• Immunologic, toxicologic and marrow transplantation studies in dogs given dimethyl myleran.

  1974cited by this paper
• Effect of busulfan on antibody production and skin allograft survival in the rat.

  1974cited by this paper
• Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia

  1971cited by this paper
• Bone-marrow Transplantation after Antilymphocytic Serum and Lethal Chemotherapy

  1969cited by this paper
• THE BINDING OF MYOGLOBIN BY PLASMA PROTEIN

  1960cited by this paper
• THE INFLUENCE OF 1,4‐DIMETHYLSULFONOXY‐1,4‐DIMETHYLBUTANE (CB 2348, DIMETHYL MYLERAN) IN NEOPLASTIC DISEASE

  1958cited by this paper
• ‘Actively Acquired Tolerance’ of Foreign Cells

  1953cited by this paper

• Hematopoietic reconstitution of neonatal immunocompetent mice to study conditions with a perinatal window of susceptibility

  2018cites this paper
• Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen

  2016cites this paper
• EGFP-transgenic skin grafts in mice EGFP-expressing bone marrow and subsequent acceptance of Nonmyeloablative conditioning is sufficient to allow engraftment of

  2013cites this paper
• irradiation, and posttransplantation cyclophosphamide after nonmyeloablative conditioning with fludarabine, low-dose total body incompatible cells - Durable engraftment of major histocompatibility complex

  2013cites this paper
• Regulatory cells and transplantation tolerance.

  2013cites this paper
• Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan

  2013cites this paper
• Maternal T-cell engraftment associated with severe hemophagocytosis of the bone marrow in untreated X-linked severe combined immunodeficiency.

  2008cites this paper
• [The future of immunotherapy for composite tissues allotransplantation].

  2007cites this paper
• Non‐myeloablative mixed chimerism approaches and tolerance, a split decision

  2007cites this paper
• Perspectives en immunothérapie des allogreffes de tissus composites

  2007cites this paper
• T regulatory cells as an immunotherapy for transplantation

  2006cites this paper
• Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning

  2006cites this paper
• Les voies de recherche en immunologie appliquées à l'allotransplantation de tissus composites

  2006cites this paper
• [Future research in immunology for composite tissue allotransplantation].

  2006cites this paper
• The Tale of Early Hematopoietic Cell Seeding in the Bone Marrow Niche

  2006cites this paper
• Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round

  2005cites this paper
• Regulatory T cells and organ transplantation.

  2004cites this paper
• Prolongation of Skin Allograft Survival after Neonatal Injection of Donor Bone Marrow and Epidermal Cells

  2004cites this paper
• A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic nod mice

  2003cites this paper
• Nonmyeloablative conditioning is sufficient to allow engraftment of EGFP-expressing bone marrow and subsequent acceptance of EGFP-transgenic skin grafts in mice.

  2003cites this paper
• Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers

  2003cites this paper
• In vivo imaging studies of the effect of recipient conditioning, donor cell phenotype and antigen disparity on homing of haematopoietic cells to the bone marrow

  2003cites this paper
• New trends and future directions of research in hand and composite tissue allotransplantation

  2003cites this paper
• Allogeneic chimerism established with a mixture of low dose bone marrow cells and splenocytes in sublethally irradiated mice.

  2002cites this paper
• Reprogramming the immune system

  2002cites this paper
• Murine Models of Bone-Marrow Transplant Conditioning

  2002cites this paper
• Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide.

  2001cites this paper
• New method for thyroid transplantation across major histocompatibility complex barriers using allogeneic bone marrow transplantation.

  2001cites this paper
• Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation.

  2001cites this paper
• A New Method for Tolerance Induction: Busulfan Administration Followed by Intravenous Injection of Neuraminidase‐Treated Donor Bone Marrow

  2001cites this paper
• Approaching Tolerance in Transplantation

  2001cites this paper
• Induction of Permanent Mixed Chimerism and Skin Allograft Tolerance Across Fully MHC-Mismatched Barriers by the Additional Myelosuppressive Treatments in Mice Primed with Allogeneic Spleen Cells Followed by Cyclophosphamide1

  2000cites this paper
• High dose bone marrow transplantation induces deletion of antigen-specific T cells in a Fas-independent manner.

  2000cites this paper
• Cyclophosphamide with Allogeneic Spleen Cells Followed by PrimedMyelosuppressive Treatments in Mice MHC-Mismatched Barriers by the Additional and Skin Allograft Tolerance Across Fully Induction of Permanent Mixed Chimerism and Kikuo

  2000cites this paper
• CD4 T cells can reject major histocompatibility complex class I‐incompatible skin grafts

  1999cites this paper
• Transplantation tolerance—where do we stand?

  1999cites this paper
• Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment.

  1999cites this paper
• Approach to withdrawal from tacrolimus in a fully allogeneic murine skin graft model

  1999cites this paper
• Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.

  1999cites this paper
• How do monoclonal antibodies induce tolerance? A role for infectious tolerance?

  1998cites this paper
• Specific tolerance induction and organ transplantation.

  1998cites this paper
• Haematopoietic stem cells can induce specific skin graft acceptance across full MHC barriers

  1998cites this paper
• An alternative conditioning regimen for induction of specific skin graft tolerance across full major histocompatibility complex barriers.

  1998cites this paper
• Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose.

  1998cites this paper
• Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.

  1997cites this paper
• A role for Th2 cytokines in the suppression of CD8+ T cell‐mediated graft rejection

  1997cites this paper
• Specific tolerance induction and transplantation: a single-day protocol.

  1997cites this paper
• Split tolerance induced by immunotoxin in a rhesus kidney allograft model.

  1997cites this paper
• Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys.

  1997cites this paper
• A substantial level of mixed chimerism is required for the induction of permanent transplantation tolerance.

  1996cites this paper
• Immunotherapy of insulin-dependent diabetes mellitus: Tolerance after short-term anti—;IL-2 receptor/cyclosporine therapy in BB/OK rats

  1996cites this paper
• Mechanisms of Peripheral Tolerance and Suppression Induced by Monoclonal Antibodies to CD4 and CD8

  1996cites this paper
• Evidence for the presence of hematopoietic stem cells in the adult liver.

  1995cites this paper
• Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.

  1995cites this paper
• Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice

  1995cites this paper
• In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium.

  1995cites this paper
• Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: a review of efficacy and mechanisms.

  1995cites this paper
• Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.

  1995cites this paper
• FUTURE GOALS FOR THERAPEUTIC MONOCLONAL ANTIBODIES

  1995cites this paper
• Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.

  1994cites this paper
• Anti-CD3 treatment facilitates engraftment of full H-2-disparate donor bone marrow cells and subsequent skin allograft tolerance.

  1994cites this paper
• Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs.

  1994cites this paper
• CAMPATH-1 Monoclonal Antibodies in Bone Marrow Transplantation

  1994cites this paper
• THE IMPORTANCE OF NONIMMUNE FACTORS IN RECONSTITUTION BY DISCORDANT XENOGENEIC HEMATOPOIETIC CELLS1,2

  1994cites this paper
• The use of monoclonal antibodies to achieve immunological tolerance.

  1993cites this paper
• Selective Depletion of Alloreactive Cells in Transplantation

  1993cites this paper
• The use of monoclonal antibodies to achieve immunological tolerance.

  1993cites this paper